Chemodex

Psoralen

CHF 68.00
In stock
CDX-P0593-M01010 mgCHF 68.00
CDX-P0593-M02525 mgCHF 122.00
CDX-P0593-M100100 mgCHF 366.00
More Information
Product Details
Synonyms Ficusin; Furocoumarin; 6,7-Furanocoumarin; NSC 404562; 7H-Furo[3,2-g]benzopyran-7-one; Furo[3,2-g]coumarin
Product Type Chemical
Properties
Formula C11H6O3
MW 186.16
CAS 66-97-7
RTECS LV0944000
Source/Host Chemicals Isolated from plant source.
Purity Chemicals ≥98% (HPLC)
Appearance White to off-white powder.
Solubility Soluble in DMSO (20mg/ml), DMF (20mg/ml), ethanol (5 mg/ml), ethyl acetate, acetone or water (1mg/ml with warming).
Identity Determined by 1H-NMR.
Declaration Manufactured by Chemodex.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

InChi Key ZCCUUQDIBDJBTK-UHFFFAOYSA-N
Smiles O=C1C=CC2=C(C=C(OC=C3)C3=C2)O1
Shipping and Handling
Shipping AMBIENT
Short Term Storage +20°C
Long Term Storage +4°C
Handling Advice Protect from light and moisture.
Use/Stability Stable for at least 2 years after receipt when stored at +4°C.
Documents
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Description

Psoralen is a photoactive probe that has been used to investigate nucleic acid structure and function. It intercalates into DNA and, when activated by ultraviolet radiation, can create covalent interstrand crosslinks, inducing apoptosis. Photosensitizing agent that shows anticancer properties by inducing apoptosis and cell cycle arrest, modulating the Wnt/β-catenin pathway. This compound is also used in molecular biology applications. Because of its high UV absorbance, psoralen has been combined with UVA light (PUVA therapy) for the treatment of skin problems such as psoriasis, eczema, vitiligo, and cutaneous T-cell lymphoma. Spectral fluorescence: λex=335nm; λem=460nm (pH 7.0).

Product References

(1) K.M. Vasquez; Environ. Mol. Mutagen 51, 527 (2010) | (2) A. Litovchick, et al.; Artif.DNA PNA XNA 5, (2014) | (3) X. Wang, et al.; Biol. Pharm. Bull. 39, 815 (2016) | (4) M. Oldham, et al.; PLoS One 11, e0162078 (2016) | (5) F. Kouzine, et al.; Methods Mol. Biol. 1703, 95 (2018) | (6) X. Wang, et al.; Sci. Rep. 8, 14001 (2018) | (7) J. Guitart; JAMA Dermatol. 155, 529 (2019) |(8) X. Wang, et al.; Biol. Res. 52, 34 (2019)

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.